Erasca (ERAS) Enterprise Value (2020 - 2026)
Erasca (ERAS) posted Enterprise Value of -$243.8 million for Q1 2026, up 11.7% on a QoQ basis from -$276.1 million in Q4 2025, and up 19.96% year-over-year from -$203.2 million in Q1 2025.
Erasca (ERAS) Enterprise Value (2020 - 2026) Analysis & Trends
Erasca's Enterprise Value history runs 7 years deep, the most recent figure standing at -$243.8 million for Q1 2026.
- Quarterly Enterprise Value rose 19.96% year-over-year to -$243.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$243.8 million (up 19.96% YoY) and the FY2025 annual result came in at -$276.1 million, up 7.45% from the prior year.
- Enterprise Value was -$243.8 million for Q1 2026 at Erasca, up from -$276.1 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$243.8 million in Q1 2026 and bottomed at -$435.6 million in Q4 2022.
- A 5-year average of -$330.9 million and a median of -$312.3 million in 2023 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value plunged 130.92% — and 2023, when it increased 28.3%.
- Erasca's Enterprise Value stood at -$435.6 million in 2022, then rose by 28.3% to -$312.3 million in 2023, then grew by 4.5% to -$298.3 million in 2024, then rose by 7.45% to -$276.1 million in 2025, then increased by 11.7% to -$243.8 million in 2026.
- Business Quant data shows ERAS's Enterprise Value at -$243.8 million in Q1 2026, -$276.1 million in Q4 2025, and -$288.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Erasca | 5.89 Bn | 5.89 Bn | - | -243.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -243.79 Mn |
| Dec 31, 2025 | -276.08 Mn |
| Sep 30, 2025 | -288.40 Mn |
| Jun 30, 2025 | -300.66 Mn |
| Mar 31, 2025 | -304.59 Mn |
| Dec 31, 2024 | -298.31 Mn |
| Sep 30, 2024 | -318.91 Mn |
| Jun 30, 2024 | -408.41 Mn |
| Mar 31, 2024 | -393.76 Mn |
| Dec 31, 2023 | -312.35 Mn |
| Sep 30, 2023 | -296.67 Mn |
| Jun 30, 2023 | -317.25 Mn |
| Mar 31, 2023 | -389.74 Mn |
| Dec 31, 2022 | -435.62 Mn |
| Sep 30, 2022 | -355.93 Mn |
| Jun 30, 2022 | -292.73 Mn |
| Mar 31, 2022 | -392.53 Mn |
| Dec 31, 2021 | -414.48 Mn |
| Sep 30, 2021 | -486.65 Mn |
| Jun 30, 2021 | -193.67 Mn |